BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21981029)

  • 21. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
    Gloyn AL; Siddiqui J; Ellard S
    Hum Mutat; 2006 Mar; 27(3):220-31. PubMed ID: 16416420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes].
    Gach A; Gadzicka A; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):45-9. PubMed ID: 18577347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into K
    Pipatpolkai T; Usher S; Stansfeld PJ; Ashcroft FM
    Nat Rev Endocrinol; 2020 Jul; 16(7):378-393. PubMed ID: 32376986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three cases of permanent neonatal diabetes mellitus: genotypes and management outcome.
    Ooi HL; Wu LL
    Singapore Med J; 2012 Jul; 53(7):e142-4. PubMed ID: 22815030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.
    Zwaveling-Soonawala N; Hagebeuk EE; Slingerland AS; Ris-Stalpers C; Vulsma T; van Trotsenburg AS
    Diabetologia; 2011 Feb; 54(2):469-71. PubMed ID: 21109997
    [No Abstract]   [Full Text] [Related]  

  • 27. Heterozygous ABCC8 mutations are a cause of MODY.
    Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
    Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel ABCC8 mutation illustrates the variability of the diabetes phenotypes associated with a single mutation.
    Klee P; Bellanné-Chantelot C; Depret G; Llano JP; Paget C; Nicolino M
    Diabetes Metab; 2012 Apr; 38(2):179-82. PubMed ID: 22326206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permanent neonatal diabetes caused by a novel mutation.
    Jain V; Flanagan SE; Ellard S
    Indian Pediatr; 2012 Jun; 49(6):486-8. PubMed ID: 22796691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pathway to insulin independence in newborns and infants with diabetes.
    Shahawy S; Chan NK; Ellard S; Young E; Shahawy H; Mace J; Peverini R; Chinnock R; Njolstad PR; Hattersley AT; Hathout E
    J Perinatol; 2011 Aug; 31(8):567-70. PubMed ID: 21796147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.
    Hartemann-Heurtier A; Simon A; Bellanné-Chantelot C; Reynaud R; Cavé H; Polak M; Vaxillaire M; Grimaldi A
    Diabetes Metab; 2009 Jun; 35(3):233-5. PubMed ID: 19342262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KATP channel mutations in congenital hyperinsulinism.
    Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C
    Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
    Vaxillaire M; Dechaume A; Busiah K; Cavé H; Pereira S; Scharfmann R; de Nanclares GP; Castano L; Froguel P; Polak M;
    Diabetes; 2007 Jun; 56(6):1737-41. PubMed ID: 17389331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
    Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
    Proks P; Girard C; Baevre H; Njølstad PR; Ashcroft FM
    Diabetes; 2006 Jun; 55(6):1731-7. PubMed ID: 16731836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group.
    Polak M; Dechaume A; Cavé H; Nimri R; Crosnier H; Sulmont V; de Kerdanet M; Scharfmann R; Lebenthal Y; Froguel P; Vaxillaire M;
    Diabetes; 2008 Apr; 57(4):1115-9. PubMed ID: 18171712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations.
    Kapoor RR; Flanagan SE; James CT; McKiernan J; Thomas AM; Harmer SC; Shield JP; Tinker A; Ellard S; Hussain K
    Diabetologia; 2011 Oct; 54(10):2575-83. PubMed ID: 21674179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapsing diabetes can result from moderately activating mutations in KCNJ11.
    Gloyn AL; Reimann F; Girard C; Edghill EL; Proks P; Pearson ER; Temple IK; Mackay DJ; Shield JP; Freedenberg D; Noyes K; Ellard S; Ashcroft FM; Gribble FM; Hattersley AT
    Hum Mol Genet; 2005 Apr; 14(7):925-34. PubMed ID: 15718250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permanent diabetes during the first year of life: multiple gene screening in 54 patients.
    Russo L; Iafusco D; Brescianini S; Nocerino V; Bizzarri C; Toni S; Cerutti F; Monciotti C; Pesavento R; Iughetti L; Bernardini L; Bonfanti R; Gargantini L; Vanelli M; Aguilar-Bryan L; Stazi MA; Grasso V; Colombo C; Barbetti F;
    Diabetologia; 2011 Jul; 54(7):1693-701. PubMed ID: 21544516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.
    Babiker T; Vedovato N; Patel K; Thomas N; Finn R; Männikkö R; Chakera AJ; Flanagan SE; Shepherd MH; Ellard S; Ashcroft FM; Hattersley AT
    Diabetologia; 2016 Jun; 59(6):1162-6. PubMed ID: 27033559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.